CSIMarket
 


Redhill Biopharma Ltd   (RDHL)
Other Ticker:  
 
 

RDHL's Net Income Growth by Quarter and Year

Redhill Biopharma Ltd 's Net Income results by quarter and year




RDHL Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 71.67 97.74 76.17 42.30
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   71.67 97.74 76.17 42.30



RDHL Net Income fourth quarter 2022 Y/Y Growth Comment
Redhill Biopharma Ltd reported fall in Net Income in the fourth quarter 2022 by -26.67% to $ 71.67 millions, from the same quarter in 2021.
The drop in the fourth quarter 2022 Redhill Biopharma Ltd 's Net Income compares unfavorably to the Company's average Net Income decrease of -4.01%.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 30 other companies have achieved higher Net Income growth. While Redhill Biopharma Ltd ' s Net Income drop of -26.67% ranks overall at the positon no. 1642 in the fourth quarter 2022.




RDHL Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December -26.67 % 28.32 % 80.07 % 8.96 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -26.67 % 28.32 % 80.07 % -15.3 %

Financial Statements
Redhill Biopharma Ltd 's fourth quarter 2022 Net Income $ 71.67 millions RDHL's Income Statement
Redhill Biopharma Ltd 's fourth quarter 2021 Net Income $ 97.74 millions Quarterly RDHL's Income Statement
New: More RDHL's historic Net Income Growth >>


RDHL Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -26.67 % 28.32 % 80.07 % -15.3 %




Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #31
Healthcare Sector #108
Overall #1642

Net Income Y/Y Growth Statistics
High Average Low
80.06 % -4.01 % -100 %
(Dec 31 2020)   0
Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #31
Healthcare Sector #108
Overall #1642
Net Income Y/Y Growth Statistics
High Average Low
80.06 % -4.01 % -100 %
(Dec 31 2020)   0

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Redhill Biopharma Ltd 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RDHL's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RDHL's IV. Quarter Q/Q Net Income Comment


Redhill Biopharma Ltd 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
0
12 Months Ending
(Dec 31 2020)
Cumulative Net Income 12 Months Ending $ 71.67 $ 0.00 $ 97.74 $ 0.00 $ 76.17
Y / Y Net Income Growth (TTM) -26.68 % - 28.32 % - 80.06 %
Year on Year Net Income Growth Overall Ranking # 1023 # 0 # 0 # 0 # 1079
Seqeuential Net Income Change (TTM) -26.68 % - 28.32 % - 80.06 %
Seq. Net Income Growth (TTM) Overall Ranking # 1023 # 0 # 0 # 0 # 1079




Cumulative Net Income growth Comment
Redhill Biopharma Ltd showed decline, but improvement compare to trailing twelve month Net Income decrease in 0. If the fiscal year would end in Dec 31 2022, Redhill Biopharma Ltd 's annual Net Income rise would be -26.68% year on year to $72 millions.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 1023.

Net Income TTM Q/Q Growth Statistics
High Average Low
80.06 %
15.18 %
-26.68 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 59
Overall # 1023

Net Income TTM Y/Y Growth Statistics
High Average Low
80.06 %
15.18 %
-26.68 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 59
S&P 500 # 1023
Cumulative Net Income growth Comment
Redhill Biopharma Ltd showed decline, but improvement compare to trailing twelve month Net Income decrease in 0. If the fiscal year would end in Dec 31 2022, Redhill Biopharma Ltd 's annual Net Income drop would be -26.68% year on year to $72 millions.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 1023.

Net Income TTM Q/Q Growth Statistics
High Average Low
80.06 %
15.18 %
-26.68 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 59
Overall # 1023

Net Income TTM Y/Y Growth Statistics
High Average Low
80.06 %
15.18 %
-26.68 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 59
S&P 500 # 1023




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
RDHL's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for RDHL's Competitors
Net Income Growth for Redhill Biopharma Ltd 's Suppliers
Net Income Growth for RDHL's Customers

You may also want to know
RDHL's Annual Growth Rates RDHL's Profitability Ratios RDHL's Asset Turnover Ratio RDHL's Dividend Growth
RDHL's Roe RDHL's Valuation Ratios RDHL's Financial Strength Ratios RDHL's Dividend Payout Ratio
RDHL's Roa RDHL's Inventory Turnover Ratio RDHL's Growth Rates RDHL's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2022
Halozyme Therapeutics Inc -1.29%$ -1.293 millions
Inmode Ltd -2.15%$ -2.153 millions
Vanda Pharmaceuticals Inc -3.07%$ -3.066 millions
Pro dex Inc -4.97%$ -4.973 millions
Iradimed Corporation-5.63%$ -5.627 millions
Polypid Ltd -7.15%$ -7.145 millions
Amedisys Inc -7.24%$ -7.245 millions
Biontech Se-8.34%$ -8.337 millions
Lemaitre Vascular Inc -8.87%$ -8.874 millions
Alcon inc -10.90%$ -10.904 millions
Acadia Healthcare Company Inc -11.71%$ -11.709 millions
Intuitive Surgical Inc -12.02%$ -12.020 millions
Eton Pharmaceuticals Inc -12.22%$ -12.223 millions
Steris Plc-13.82%$ -13.815 millions
Envista Holdings Corporation-14.34%$ -14.336 millions
Pharming Group N v -14.52%$ -14.516 millions
Bristol myers Squibb Company-14.63%$ -14.629 millions
Amgen Inc -14.90%$ -14.903 millions
Stryker Corp-14.95%$ -14.955 millions
Exagen Inc -15.49%$ -15.489 millions
Zynex inc -16.21%$ -16.213 millions
Uniqure N v -17.07%$ -17.069 millions
Qiagen N v -17.44%$ -17.438 millions
Merck and Co Inc -19.90%$ -19.899 millions
Chemed Corporation-21.27%$ -21.266 millions
Rapid Micro Biosystems Inc -22.31%$ -22.312 millions
Select Medical Holdings Corp-23.04%$ -23.037 millions
Baxter International Inc -23.55%$ -23.554 millions
Integer Holdings Corporation-23.84%$ -23.843 millions
Becton Dickinson And Company-24.93%$ -24.926 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com